In patients with hypertrophic cardiomyopathy (HCM), the first-in-class cardiac myosin inhibitor mavacamten (MyoKardia), on top of medical therapy, significantly improved hemodynamics, functional ...
LISBON, Portugal—Patients with obstructive hypertrophic cardiomyopathy (HCM) treated with aficamten (Cytokinetics), an inhibitor of cardiac myosin, had statistically significant and clinically ...
The Six-Minute Walk Test (6MWT) is an established submaximal exercise assessment designed to quantify functional exercise capacity in diverse populations. By measuring the distance a subject can walk ...
Researchers identified a greater increase in functional capacity, the ability to perform activities of daily living, as a result of Nordic walking in patients with coronary heart disease compared to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results